Pharmaswiss Ceska republika (Bausch & Lomb UK) is recalling all unexpired batches of epinephrine (Emerade) 500µg autoinjector pens due a product component fault, says the UK's MHRA. This recall of Emerade 500µg autoinjector pens follows recent recalls of Emerade 150µg autoinjector pens (in March this year) and Emerade 300µg autoinjector pens (in April this year). [Extracted from the article]
UK patients who carry epinephrine (adrenaline) 300µg auto-injector pens (Emerade) [1] should contact their prescriber to seek a replacement product, advises the UK's MHRA. Patients informed to exchange Emerade 300 micrograms adrenaline pens for replacement pens of a different brand. [Extracted from the article]